Both menopausal hormone therapy (MHT) and anti-obesity medications (AOMs) offer powerful tools to address metabolic disruptions. This session offers a concise review of the metabolic changes associated with menopause, an overview of available MHT options, and the science behind their synergy with AOMs. A practical framework for initiating both therapies, including patient selection, optimal timing, and strategies for monitoring treatment response and side effects will be discussed. This talk is designed to equip clinicians with the tools to integrate hormonal and metabolic interventions, ultimately improving care and outcomes for women navigating midlife and beyond.

CME/CE Expiration Date: 4/12/29

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.